首页 › 基金 › Opaleye Management Inc. › PHAT
Opaleye Management Inc. 对 PHAT 的持仓历史
Phathom Pharmaceuticals, Inc. · 医疗保健
Opaleye Management Inc. 在 Q2 2026 的 13F 申报中披露持有 PHAT(Phathom Pharmaceuticals, Inc.)185,589 股,市值约 US$2.0M,约占其申报组合的 0.18%,在其申报持仓中市值排名第 46 位。 Opaleye Management Inc. 于 Q2 2026 首次申报该持仓。
最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR
Opaleye Management Inc. 对 PHAT 的持仓演变
Opaleye Management Inc. 于 Q2 2026 首次披露 PHAT 持仓:185,589 股(约 US$2.0M)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q2 2026 | 185.59K | $2.01M | 新进 |
关于 PHAT 与 13F 数据
PHAT(Phathom Pharmaceuticals, Inc.)属于医疗保健行业。我们追踪的基金中还有 31 只申报持有 PHAT,申报仓位最大的包括:Frazier Life Sciences Management, L.P. (US$135.3M), Medicxi Ventures Management (Jersey) Ltd (US$81.0M), Carlyle Group Inc. (US$37.9M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 PHAT 的基金
- Frazier Life Sciences Management, L.P. 12.47M 股 · $135.26M · Q2 2026
- Medicxi Ventures Management (Jersey) Ltd 7.46M 股 · $80.99M · Q2 2026
- Carlyle Group Inc. 3.50M 股 · $37.94M · Q2 2026
- NEA Management Company, LLC 1.96M 股 · $21.27M · Q2 2026
- 683 Capital Management, LLC 1.85M 股 · $20.07M · Q2 2026
- Catalys Pacific, LLC 1.88M 股 · $13.74M · Q3 2026
- Propel Bio Management, LLC 1.05M 股 · $11.40M · Q2 2026
- EcoR1 Capital, LLC 625.00K 股 · $6.78M · Q2 2026
更多关于 Opaleye Management Inc.
常见问题
How long has Opaleye Management Inc. held PHAT?
Opaleye Management Inc. has disclosed PHAT holdings in 1 of the last 1 reported quarters, going back to Q2 2026.
What is Opaleye Management Inc.'s current position in PHAT?
As of Q2 2026, Opaleye Management Inc. holds 185.59K shares of PHAT (Phathom Pharmaceuticals, Inc.), valued at $2.01M, representing 0.18% of its reported portfolio and ranking #46.
Has Opaleye Management Inc. been buying or selling PHAT?
In the latest 13F filing (Q2 2026), Opaleye Management Inc. newly opened its position in PHAT.
Which other funds hold PHAT?
Other major institutional holders of PHAT include Frazier Life Sciences Management, L.P., Medicxi Ventures Management (Jersey) Ltd, Carlyle Group Inc., among 31 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.